MedPath

Preoperative oral pregabalin 150 mg versus 300 mg in total hip arthroplasty: effects on duration of spinal anesthesia and postoperative pai

Phase 1
Not yet recruiting
Conditions
Orthopaedics
Anaesthesia
Registration Number
PACTR202201644616894
Lead Sponsor
Mansoura University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
129
Inclusion Criteria

A total of 129 patients scheduled to undergo total hip arthroplasty under spinal anesthesia, aged 40-60 years, and ASA I-II will be enrolled in this study.

Exclusion Criteria

Exclusion criteria will include: (1) uncooperative patient, (2) allergy or contraindication to pregabalin, (3) preoperative use of antidepressants or anticonvulsants, (4)preoperative routine use of non-steroidal anti-inflammatory drugs (NSAIDs) or opioids, (5) drug or alcohol abuse, (6) history of diabetes mellitus, (7) impaired kidney function.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.